Reminder: OOS Survey - Participation possible until 8 April
Recommendation

20/21 October 2026
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
As reported in our last newsletter, the ECA Analytical Quality Control Group (AQCG) is currently collecting input via a short survey to support the revision and update of its guidance on Out-of-Specification (OOS) investigations.
If you have not yet participated, participation is still possible until 8 April 2026.
All responses will be evaluated in an aggregated and fully anonymized manner. None of the questions are mandatory, and participants may skip any questions they prefer not to answer. At the end of the survey, respondents are also invited to propose additional topics or questions that AQCG should consider in future guidance documents.
The revision of the guideline is planned immediately after the survey closes, and a summary report of the survey results will be prepared and made available to all members.
Thank you for your valuable time and support.
Related GMP News
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
30.09.2026The Relationship between the BP and the Ph. Eur.
30.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
30.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence

